Routine replacement versus clinical monitoring of peripheral intravenous catheters in a regional hospital in the home program: A randomized controlled trial.
This randomized, controlled trial involving 316 patients in the home setting found no difference in the rate of phlebitis and/or occlusion among patients for whom a peripheral intravenous catheter was routinely resited at 72-96 hours and those for whom it was replaced only on clinical indication (76.8 events per 1,000 device-days vs 87.3 events per 1,000 device-days; P = .71). There were no bloodstream infections.
Van Donk
Patricia
P
Latrobe Regional Hospital, Traralgon, Australia. TVanDonk@lrh.com.au
Rickard
Claire M
CM
McGrail
Matthew R
MR
Doolan
Glenn
G
D002406:Catheterization, Peripheral / Q000009:adverse effects / Q000295:instrumentation; D002408:Catheters, Indwelling / Q000009:adverse effects; D020878:Device Removal / Q000295:instrumentation*; D004866:Equipment Contamination / Q000517:prevention & control; D005260:Female; D006699:Home Care Services / Q000639:trends; D006801:Humans; D008297:Male; D008875:Middle Aged; D010689:Phlebitis / Q000453:epidemiology* / Q000209:etiology; D011793:Queensland; D016896:Treatment Outcome